Tag: SARS

Human trials of India’s first indigenous experimental vaccine against COVID-19, COVAXIN, developed by Bharat Biotech is set to begin across India in July........................

Clinical trial of the drug that has shown anti-SARS-CoV-2 effects in in-vitro studies conducted in collaboration with ICGEB will be conducted across 12 centers in India in 210 patients; results expected by October 2020.............................

Syngene has indigenously developed an anti-COV-2 IgG ELISA (Enzyme-Linked Immunosorbent Assay) at its research facility in Bengaluru. Having partnered with Hi-Media, the commercialized kit will be launched under the brand name ELISafe 19...............

CSIR through its NMITLI program approves a multi institutional project to develop human monoclonal antibodies (hmAbs) that can neutralize SARS-CoV-2 in patients. The project will be implemented by National Centre for Cell Science (NCCS), IIT-Indore and PredOmix Technologies with Bharat Biotech International, as the commercialization partner...........................

A new study by Indian Institute of Technology (IIT), Jodhpur has highlighted that loss of smell and taste of infected patients makes their entire Central Nervous System (CNS) and the underlying structures in the brain more prone to viral infection with devastating effects.................

A kit under development by the researchers at Rajiv Gandhi Centre for Biotechnology (RGCB), Thiruvananthapuram promises to help detect SARS CoVID-19 infection as early as four days post-infection of the virus...................

CSIR-Centre for Cellular and Molecular Biology (CCMB), Hyderabad is employing several tools and approaches in the fight against COVID-19 pandemic.....................

Exploring the potential to repurpose marketed products and molecules, the company is developing Anti-SARS-CoV-2 polyclonal hyperimmune globulin (H-IG) to treat infected, high-risk individuals with COVID-19...................